Parkinson hastalığında disfaji için farmakolojik tedavinin etkinliği: bir anlatı incelemesi.
Effectiveness of pharmacologic treatment for dysphagia in Parkinson's disease: a narrative review.
DOI: 10.1007/s10072-020-04865-wPMID: 33201362
Effectiveness of pharmacologic treatment for dysphagia in Parkinson's disease: a narrative review.
DOI: 10.1007/s10072-020-04865-wPMID: 33201362
Lessons From George Floyd: Racial Inequalities in the Treatment of Parkinson's Disease.
DOI: 10.1002/mds.28388PMID: 33200830
Brain Delivery of Nanomedicines: Trojan Horse Liposomes for Plasmid DNA Gene Therapy of the Brain.
DOI: 10.3389/fmedt.2020.602236PMID: 35047884
Dementia Diagnoses and Treatment in Geriatric Ward Patients: A Cross-Sectional Study in Poland.
DOI: 10.2147/cia.s281723PMID: 33223824
Therapeutics potentiating microglial p21-Nrf2 axis can rescue neurodegeneration caused by neuroinflammation.
DOI: 10.1126/sciadv.abc1428PMID: 33188020
Use of leptin-conjugated phosphatidic acid liposomes with resveratrol and epigallocatechin gallate to protect dopaminergic neurons against apoptosis for Parkinson's disease therapy.
DOI: 10.1016/j.actbio.2020.11.015PMID: 33189953
COVID-19 in age-related neurodegenerative diseases: is there a role for vitamin D3 as a possible therapeutic strategy?
DOI: 10.1515/revneuro-2020-0074PMID: 33185582
A case study of foliglurax, the first clinical mGluR4 PAM for symptomatic treatment of Parkinson's disease: translational gaps or a failing industry innovation model?
DOI: 10.1080/13543784.2020.1839047PMID: 33074728
The role of Nrf2 in neural stem/progenitors cells: From maintaining stemness and self-renewal to promoting differentiation capability and facilitating therapeutic application in neurodegenerative disease.
DOI: 10.1016/j.arr.2020.101211PMID: 33186670
Pivotal Role of Fyn Kinase in Parkinson's Disease and Levodopa-Induced Dyskinesia: a Novel Therapeutic Target?
DOI: 10.1007/s12035-020-02201-zPMID: 33175322
Recent advances in understanding and treatment of Parkinson's disease.
DOI: 10.12703/b/9-6PMID: 33659938
Target Enzymes Considered for the Treatment of Alzheimer's Disease and Parkinson's Disease.
DOI: 10.1155/2020/2010728PMID: 33224974
Kayıtlar bilimsel kaynaklardan alınır. Bibliyografik kayıt sayısı, Türkçe çeviri veya editoryal onay sayısı değildir.